Gilead's Spokesperson Confirms Remdesivir Trial In China In Patients With Severe Disease Was 'Terminated Early Due To Low Enrollment'; Trial In China In Patients With Moderate Disease Now Listed On Clinicaltrials.gov As Suspended
Benzinga Newsdesk